This company has been marked as potentially delisted and may not be actively trading. Sierra Oncology (SRRA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SRRA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Sierra Space eyes IPO market as it braces for a 'profound industrial revolution' in spaceApril 11, 2024 | msn.comSierra Oncology Inc.February 21, 2024 | thestreet.comSierra Coupon for OctoberNovember 9, 2023 | time.comTFDA approves GSK's unique myelofibrosis treatment OjjaaraSeptember 18, 2023 | msn.comPleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology DealSeptember 18, 2023 | msn.comFDA approves GSK's Ojjaara for treatment of myelofibrosis-related anaemiaSeptember 18, 2023 | msn.comAnalyst calls of the week: Palo Alto upped, Carnival earnings preview and moreJune 16, 2023 | proactiveinvestors.comSierra Oncology (NASDAQ: SRRA)June 12, 2023 | fool.comCelyad Oncology Stock (NASDAQ:CYAD), Quotes and News SummaryFebruary 25, 2023 | benzinga.comSierra LeoneFebruary 22, 2023 | bbc.co.ukInterventional Oncology Global Market - Forecast To 2029January 20, 2023 | finance.yahoo.comGSK Signs Deal to Develop Antibodies for Treating CancerJanuary 5, 2023 | nasdaq.comSareum Holdings Says Sierra Oncology To Return Cancer Treatment License; Shares FallOctober 12, 2022 | marketwatch.comCompanion Diagnostic Tests in Oncology Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2027September 25, 2022 | marketwatch.com15 Biotech Firms That Have Strong Potential to Be Acquired: JefferiesSeptember 1, 2022 | thestreet.comSierra Leone passes new laws to boost landowners' rightsAugust 8, 2022 | yahoo.comSareum Holdings Says GSK Completes Acquisition of Sierra OncologyJuly 4, 2022 | marketwatch.comSierra Oncology (Nasdaq:SRRA) HeadlineTrading was temporarily halted for "SRRA" at 07:06 PM with a stated reason of "News pending."...July 1, 2022 | marketbeat.comSierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug AdministrationJune 17, 2022 | finance.yahoo.comSierra Oncology hits 52w high – but will it continue?June 13, 2022 | uk.finance.yahoo.comSierra Oncology, Inc. (NASDAQ:SRRA) Given Consensus Rating of "Hold" by BrokeragesJune 3, 2022 | marketbeat.comMomelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual MeetingMay 26, 2022 | finance.yahoo.com-$0.95 Earnings Per Share Expected for Sierra Oncology, Inc. (NASDAQ:SRRA) This QuarterMay 22, 2022 | marketbeat.comSierra Oncology (NASDAQ:SRRA) Downgraded to Hold at Zacks Investment ResearchMay 18, 2022 | marketbeat.comShort Interest in Sierra Oncology, Inc. (NASDAQ:SRRA) Decreases By 55.9%May 13, 2022 | marketbeat.comSierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual MeetingMay 12, 2022 | finance.yahoo.comSierra Oncology, Inc. (NASDAQ:SRRA) Receives Consensus Rating of "Hold" from AnalystsMay 9, 2022 | marketbeat.comSierra Oncology Reports First Quarter 2022 ResultsMay 6, 2022 | finance.yahoo.comSIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRAMay 2, 2022 | stockhouse.comBiotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & MoreApril 14, 2022 | msn.comAnalyzing Sierra Oncology Inc's Short InterestApril 14, 2022 | msn.comAnalyst Ratings for Sierra OncologyApril 14, 2022 | markets.businessinsider.comSHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.April 13, 2022 | prnewswire.comGlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash DealApril 13, 2022 | finance.yahoo.comSierra Oncology Stock Is Soaring: Here's WhyApril 13, 2022 | markets.businessinsider.comWhy Is Sierra Oncology (SRRA) Stock Up Today?April 13, 2022 | investorplace.comGlaxoSmithKline to buy Sierra Oncology for $1.9 billionApril 13, 2022 | msn.comGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnApril 13, 2022 | finance.yahoo.comGSK Agrees To Acquire Sierra Oncology For $1.9 BlnApril 13, 2022 | nasdaq.comSRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to ShareholdersApril 13, 2022 | tmcnet.comGSK to buy Sierra Oncology for $1.9 bln in boost to blood cancer opsApril 13, 2022 | reuters.comSierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKlineApril 13, 2022 | barrons.comSierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoApril 13, 2022 | finance.yahoo.comBiotech Feeding Spree As GSK, Halozyme Announce Nearly $3 Billion In DealsApril 13, 2022 | finance.yahoo.comOppenheimer Increases Sierra Oncology (NASDAQ:SRRA) Price Target to $45.00March 14, 2022 | marketbeat.comSierra Oncology Non-GAAP EPS of -$1.44March 11, 2022 | seekingalpha.comSierra Oncology Reports 2021 Year End ResultsMarch 10, 2022 | finance.yahoo.comHarley-Davidson, SOC Telemed Stocks See Action From Activist InvestorsFebruary 11, 2022 | finance.yahoo.comSierra Oncology raises additional funds from underwriters of stock offeringFebruary 3, 2022 | seekingalpha.comSierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesFebruary 3, 2022 | finance.yahoo.com Get Sierra Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SRRA and its competitors with MarketBeat's FREE daily newsletter. Email Address SRRA Media Mentions By Week SRRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRRA News Sentiment▼0.001.01▲Average Medical News Sentiment SRRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRRA Articles This Week▼00▲SRRA Articles Average Week Get Sierra Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SRRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Calliditas Therapeutics AB (publ) News Zymeworks News Chimerix News Avid Bioservices News MBX Biosciences News Revance Therapeutics News Checkpoint Therapeutics News 2seventy bio News Acelyrin News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRRA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sierra Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sierra Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRRA Stock Alerts